Acro Biomedical (ACBM) Long-Term Deferred Tax (2018 - 2019)
Acro Biomedical's quarterly Long-Term Deferred Tax came in at $9871.0 in Q2 2019, down 84.83% quarter-over-quarter from $65065.0 in Q1 2019.
Acro Biomedical has reported Long-Term Deferred Tax for 2 years, with the latest figure at $9871.0 in Q2 2019.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | EQV Ventures Acquisition | 477.69 Mn | 477.69 Mn | - |
| 2 | Berto Acquisition | 316.66 Mn | 316.66 Mn | - |
| 3 | Centurion Acquisition | 311.94 Mn | 311.94 Mn | - |
| 4 | Churchill Capital Corp IX | 311.36 Mn | 311.36 Mn | - |
| 5 | Agriculture & Natural Solutions Acquisition | 301.94 Mn | 301.94 Mn | - |
| 6 | Siddhi Acquisition Corp (Cayman Islands) | 286.76 Mn | 286.76 Mn | - |
| 7 | Bold Eagle Acquisition | 276.06 Mn | 276.06 Mn | - |
| 8 | Cartesian Growth Corp III | 270.68 Mn | 270.68 Mn | - |
| 9 | Oyster Enterprises II Acquisition | 266.84 Mn | 266.84 Mn | - |
| 10 | Acro Biomedical | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2019 | 9,871.00 |
| Mar 31, 2019 | 65,065.00 |
| Dec 31, 2018 | 19,941.00 |